128 related articles for article (PubMed ID: 37505259)
1. Retraction Note: Alterations in circulating vasoactive substances in the critically ill-a comparison between survivors and non-survivors.
Boldt J; Menges T; Kuhn D; Diridis C; Hempelmann G
Intensive Care Med; 2023 Oct; 49(10):1281. PubMed ID: 37505259
[No Abstract] [Full Text] [Related]
2. Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors.
Boldt J; Menges T; Kuhn D; Diridis C; Hempelmann G
Intensive Care Med; 1995 Mar; 21(3):218-25. PubMed ID: 7790607
[TBL] [Abstract][Full Text] [Related]
3. Retraction Note: Circulating adhesion molecules in the critically ill: A comparison between trauma and sepsis patients.
Boldt J; Müller M; Kuhn D; Linke LC; Hempelmann G
Intensive Care Med; 2023 May; 49(5):612. PubMed ID: 37016204
[No Abstract] [Full Text] [Related]
4. Retraction Note: The effects of pentoxifylline on circulating adhesion molecules in critically ill patients with acute renal failure treated by continuous veno-venous hemofiltration.
Boldt J; Müller M; Heesen M; Martin K; Hempelmann G
Intensive Care Med; 2023 Sep; 49(9):1154. PubMed ID: 37490057
[No Abstract] [Full Text] [Related]
5. Vasoactive substances and their effects on nutrition in the critically ill patient.
Allen JM
Nutr Clin Pract; 2012 Jun; 27(3):335-9. PubMed ID: 22504108
[TBL] [Abstract][Full Text] [Related]
6. Early Lactate Dynamics in Critically Ill Non-Traumatic Patients in a Resuscitation Room of a German Emergency Department (OBSERvE-Lactate-Study).
Kramer A; Urban N; Döll S; Hartwig T; Yahiaoui-Doktor M; Burkhardt R; Petros S; Gries A; Bernhard M
J Emerg Med; 2019 Feb; 56(2):135-144. PubMed ID: 30538084
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients.
Sun C; Sun Y; Wu P; Ding W; Wang S; Li J; Liang L; Chai C; Fu Y; Li Z; Zhu L; Ju J; Liao X; Huang X; Feng L; Ma D; He L; Chen D; Chen G; Jin X; Wu P
Intensive Care Med Exp; 2021 Mar; 9(1):13. PubMed ID: 33721144
[TBL] [Abstract][Full Text] [Related]
8. Significance of increased lipid peroxidation in critically ill patients.
Karbownik-Lewińska M; Kokoszko A; Jozefiak M; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):367-81. PubMed ID: 17693980
[TBL] [Abstract][Full Text] [Related]
9. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients.
Ilias I; Diamantopoulos A; Botoula E; Athanasiou N; Zacharis A; Tsipilis S; Jahaj E; Vassiliou AG; Vassiliadi DA; Kotanidou A; Tsagarakis S; Dimopoulou I
Front Endocrinol (Lausanne); 2021; 12():644055. PubMed ID: 34220703
[TBL] [Abstract][Full Text] [Related]
10. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children.
Srinivasan V; Spinella PC; Drott HR; Roth CL; Helfaer MA; Nadkarni V
Pediatr Crit Care Med; 2004 Jul; 5(4):329-36. PubMed ID: 15215001
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant Role in Critically Ill Patients with Vasodilatory Shock: Does Glutathione Peroxidase Correlate to Severity of Tissue Hypoxia and Organ Failure.
Semedi BP; Rehatta NM; Nugraha J; Soetjipto
Open Access Emerg Med; 2023; 15():133-143. PubMed ID: 37151382
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Yang X; Yu Y; Xu J; Shu H; Xia J; Liu H; Wu Y; Zhang L; Yu Z; Fang M; Yu T; Wang Y; Pan S; Zou X; Yuan S; Shang Y
Lancet Respir Med; 2020 May; 8(5):475-481. PubMed ID: 32105632
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
Ma J; Wang S; Chen D; Duan J; Li C; Li G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
[TBL] [Abstract][Full Text] [Related]
14. Non-thyroidal illness syndrome predicts outcome in adult critically ill patients: a systematic review and meta-analysis.
Vidart J; Jaskulski P; Kunzler AL; Marschner RA; Ferreira de Azeredo da Silva A; Wajner SM
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35015701
[TBL] [Abstract][Full Text] [Related]
15. Relationship among plasma amino acids, C-reactive protein, illness severity, and outcome in critically ill dogs.
Chan DL; Rozanski EA; Freeman LM
J Vet Intern Med; 2009; 23(3):559-63. PubMed ID: 19645841
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein as a predictor of mortality in critically ill patients: a meta-analysis and systematic review.
Zhang Z; Ni H
Anaesth Intensive Care; 2011 Sep; 39(5):854-61. PubMed ID: 21970129
[TBL] [Abstract][Full Text] [Related]
17. Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study.
Rouby JJ; Poète P; Martin de Lassale E; Nicolas MH; Bodin L; Jarlier V; Korinek AM; Viars P
Intensive Care Med; 1994; 20(3):187-92. PubMed ID: 8014284
[TBL] [Abstract][Full Text] [Related]
18. Role of Nuclear Factor-Kappa B Activation and Inflammatory Biomarkers in Critically Ill Children.
Reddy ASS; Rao SS; D Shenoy V; Shetty S
Indian J Pediatr; 2023 Sep; ():. PubMed ID: 37751042
[TBL] [Abstract][Full Text] [Related]
19. Retraction Note: Influence of different volume therapies on platelet function in the critically ill.
Boldt J; Müller M; Heesen M; Heyn O; Hempelmann G
Intensive Care Med; 2023 Jun; 49(6):725. PubMed ID: 37041369
[No Abstract] [Full Text] [Related]
20. Retraction note: Volume therapy in the critically ill: is there a difference?
Intensive Care Med; 2014 Jan; 40(1):145. PubMed ID: 24271030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
